Company Filing History:
Years Active: 2002
Title: The Innovative Contributions of Susan G. McGrew
Introduction
Susan G. McGrew is a notable inventor based in Nashville, TN (US). She has made significant contributions to the field of autism treatment through her innovative research and patent. Her work focuses on the modulation of in vivo glutamine and glycine levels, which has the potential to improve the lives of individuals with autism.
Latest Patents
Susan G. McGrew holds a patent for a method titled "Modulation of in vivo glutamine and glycine levels in the treatment of autism." This method involves administering an effective amount of a glutamine level reducing agent, a glycine level reducing agent, or combinations thereof to a patient. Representative glutamine level reducing agents include phenylbutyrate and phenylacetate, while sodium benzoate serves as a glycine level reducing agent. Additionally, the method may include the administration of an N-methyl-D-aspartate receptor antagonist, such as dextromethorphan.
Career Highlights
Susan G. McGrew is affiliated with Vanderbilt University, where she conducts her research and develops her innovative methods. Her work has garnered attention for its potential impact on autism treatment, showcasing her dedication to improving patient outcomes.
Collaborations
One of her notable collaborators is John A. Phillips, III. Their partnership highlights the importance of teamwork in advancing research and innovation in the medical field.
Conclusion
Susan G. McGrew's contributions to autism treatment through her patented methods exemplify the power of innovation in addressing complex health issues. Her work continues to inspire advancements in medical research and treatment strategies.